Why BioSig Technologies (BSGM) Shares Are Down Over 60%

BioSig Technologies shares are trading lower by 67% during Tuesday's session. The company said it was notified by the Nasdaq Hearings Panel that its common stock will be delisted.

BioSig Technologies (NASDAQ:BSGM) shares are trading lower by 67% to $0.55 during Tuesday’s session after the company said it was notified by the Nasdaq Hearings Panel that its common stock will be delisted from the Nasdaq Stock Market due to non-compliance with the minimum stockholders’ equity requirement.

Consequently, trading of the company’s stock will be suspended on Nasdaq starting June 12. The stock is expected to trade on the OTC Markets’ Pink Current Information tier under the symbol “BSGM” beginning the same day.

The company intends to request the Panel’s reconsideration and appeal the decision to the Nasdaq Listing and Hearing Review Council, although there is no assurance of success in these efforts.

See Also: May Inflation Report Clashes With Fed Meeting: Traders Brace For Volatile Wednesday

According to data from Benzinga Pro, BSGM has a 52-week high of $15.50 and a 52-week low of $0.26.

Total
0
Shares
Related Posts
Read More

Melinta Therapeutics & Cidara Therapeutics Announce Publication Of Pooled Data From Phase 3 Pivotal ReSTORE Trial & Phase 2 STRIVE Trial Of REZZAYO For The Treatment Of Candidemia & Invasive Candidiasis In The Lancet ID

Publication reaffirms the proven efficacy and safety of rezafungin dosed once-weekly versus a current standard of care echinocandin dosed once-dailyMelinta Therapeutics, LLC and Cidara Therapeutics, Inc. (NASDAQ:CDTX)

CDTX